1
Vascularity Impact on the Treatment Outcome in Malignant Pleural Mesothelioma(VITMPM)
Condition(s):Malignant Pleural MesotheliomasLast Updated:June 1, 2016Completed
Mesotheliomas Pleural: 253 Clinical Trials, Page 1 of 26
Hide Studies Not Open or Pending
2
Pembrolizumab Plus Lenvatinib In Second Line and Third Line Malignant Pleural mesotheLioma Patients
Condition(s):Mesotheliomas PleuralLast Updated:January 26, 2021Not yet recruiting
3
Mesothelioma Early Detection by VOCs
Condition(s):Pleural Mesothelioma; Asbestos Exposure; Pleural PlaqueLast Updated:May 13, 2020Suspended
4
Intrapleural Administration of HSV1716 to Treat Patients With Malignant Pleural Mesothelioma.
Condition(s):Malignant Pleural MesotheliomaLast Updated:June 9, 2017Completed
5
Pembrolizumab + Defactinib In Pleural Mesothelioma
Condition(s):Malignant Pleural MesotheliomaLast Updated:November 17, 2020Withdrawn
6
Safety Confirmation Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma
Condition(s):Malignant Pleural MesotheliomaLast Updated:April 11, 2007Completed
7
A Study of Atezolizumab in Unresectable or Advaced Malignant Pleural Mesothelioma
Condition(s):Malignant Pleural Mesothelioma, Advanced; Malignant Pleural Mesothelioma, UnresectableLast Updated:December 26, 2018Not yet recruiting
8
Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM)
Condition(s):Mesotheliomas PleuralLast Updated:December 23, 2020Not yet recruiting
9
Poly-ICLC (Hiltonol®) Vaccine In Malignant Pleural Mesothelioma
Condition(s):Malignant Pleural MesotheliomaLast Updated:August 25, 2020Recruiting
10
Response Evaluation in Malignant Pleural Mesothelioma
Condition(s):Malignant Pleural MesotheliomaLast Updated:August 6, 2015Unknown status